Anthropic published an interesting blog post titled "When AI Builds Itself." a couple of days ago, and if you work in financial services and haven't read it, stop what you're doing. The piece ...

A new report out today from cybersecurity company Miggo Security Ltd. details a now-mitigated vulnerability in Google LLC’s artificial intelligence ecosystem that allowed for a natural-language prompt ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

(RTTNews) - Recursion Pharmaceuticals, Inc. (RXRX), a clinical-stage TechBio company, on Monday, announced that it is deprioritizing three of its clinical programs and one preclinical program ...

NVIDIA Co. (NASDAQ: NVDA) is the undisputed leader of the artificial intelligence (AI) revolution. The company envisioned an AI future over 12 years ago and began executing the blueprint for ...

London: Nvidia-backed Recursion Pharmaceuticals said on Tuesday its experimental drug to treat a rare brain-related condition was safe and tolerable in a mid-stage study, but showed mixed results for ...

Recursion Pharmaceuticals. has been granted a patent for a method to identify target proteins using a test ligand. The process involves docking simulations, molecular data extraction, and binding site ...

The meeting, to be chaired by union finance minister Nirmala Sitharaman, the Council will take up pending issues . (Hindustan Times)(HT_PRINT) New Delhi: Federal indirect tax body, GST Council, is ...

Recursion Pharmaceuticals Co-Founder and CEO Chris Gibson joins 'Mad Money' host Jim Cramer to talk integrating machine learnings into drug development and partnering with Nvidia. Got a confidential ...